Skip to content

Evaluation of Efficacy and side effects of Q switched Nd:YAG versus fractional Er:YAG in Face rejuvenation

Evaluation of Efficacy and side effects of Q switched Nd:YAG versus fractional Er:YAG in Face rejuvenation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250417065364N1
Enrollment
20
Registered
2025-07-26
Start date
2025-06-22
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin rejuvanation.

Interventions

Intervention 1: Intervention group: One side of the face of the referred individuals will undergo laser therapy with a Q-switched laser. The Q-switched Nd:YAG laser used in the study is the IRIS devic

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age between 35 and 70 years Voluntary participation in the study

Exclusion criteria

Exclusion criteria: History of keloid formation History of coagulation disorder or use of medications that affect coagulation Uncontrolled diabetes or hypertension Active infection in the facial area within the past 1 month Unwillingness or ability to make follow-up visits at scheduled times History of skin cancer in the past 5 years

Design outcomes

Primary

MeasureTime frame
Facial texture improvement level. Timepoint: First month, second month, third month. Method of measurement: Comparison of photos by a dermatologist.;Patient Satisfaction. Timepoint: First month, second month, third month. Method of measurement: Patient Question.;Side effects. Timepoint: First month, second month, third month. Method of measurement: Patient questioning and examination by a dermatologist.

Secondary

MeasureTime frame
Improvement of facial wrinkles. Timepoint: First month, second month, third month. Method of measurement: Comparison of photos by a dermatologist.;Pain. Timepoint: First month, second month, third month. Method of measurement: Patient Question.;Erythema. Timepoint: First month, second month, third month. Method of measurement: Patient questioning and examination by a dermatologist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Isazadeh

Shahid Beheshti University of Medical Sciences

mahdiisazadeh@yahoo.com+98 21 2271 8000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026